Hydroxyprogesterone Caproate 250mg/ml in Sesame Oil — Class II drug recall D-1164-2014
Terminated recall by RX South LLC DBA RX3 Pharmacy, reported 2014-03-26, distributed in MD, VA. Crystallization; visible crystals from the active ingredient formed due to extreme cold temperatures during sh
| Recall number | D-1164-2014 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | RX South LLC DBA RX3 Pharmacy, Chester, VA, United States |
| Recall initiated | 2014-01-28 |
| Classified | 2014-03-17 |
| Reported by FDA | 2014-03-26 |
| Terminated | 2014-04-10 |
| Distributed | MD, VA |
| Quantity | 250 syringes |
| Expiration dates | 2014-06-03 |
Product
Hydroxyprogesterone Caproate 250mg/ml in Sesame Oil, 1 ml injectable solution, in 3 ml single dose syringes; a multi-ingredient compounded medication in bulk, containing Benzoyl Benzoate USP 0.46 ml/1ml, and Benzyl Alcohol 0.02 ml/1ml; syringe is labeled in part ***FOR INJECTION USE ONLY***RX South LLC DBA RX3 12230 Iron Bridge Rd Chester, VA 23831***
Reason for recall
Crystallization; visible crystals from the active ingredient formed due to extreme cold temperatures during shipping
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1164-2014. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.